Former GSK CEO and ex-R&D boss move to biotech venture firms
September 19, 2017 at 09:35 AM EDT
LONDON, Sept 19 (Reuters) - GlaxoSmithKline's former chief executive Andrew Witty and its one-time research head Moncef Slaoui both picked up new jobs in the biotech venture capital sector on Tuesday, following a route favoured by many ex-pharma executives.